Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Am Osteopath Assoc ; 93(10): 1055-9, 1993 Oct.
Article in English | MEDLINE | ID: mdl-8258536

ABSTRACT

Medical education is recognized as a legitimate cost of doing business in a teaching hospital. This article outlines the general principles and concepts currently used to determine the actual amount of financial reimbursement that a hospital receives for its graduate medical education (GME) programs. Directors of Medical Education should have a solid understanding of these principles if they are to work successfully with the hospital reimbursement experts to maximize the teaching hospital's revenue. To that end, the authors detail 10 rules to ensure that all essential elements are included in the reimbursement formulas. Also considered are the nonfinancial benefits of GME of which hospital leadership must be aware so that they may understand the total contribution that GME makes to the teaching hospital.


Subject(s)
Hospitals, Teaching/economics , Internship and Residency/economics , Training Support/legislation & jurisprudence , Education, Medical, Graduate/economics , Financial Management, Hospital/trends , Medicare Part A/legislation & jurisprudence , Medicare Part A/organization & administration , Osteopathic Medicine/economics , Osteopathic Medicine/education , Prospective Payment System , Reimbursement Mechanisms , United States
2.
J Appl Toxicol ; 9(4): 223-8, 1989 Aug.
Article in English | MEDLINE | ID: mdl-2778255

ABSTRACT

The role of aromaticity in the nephrotoxic potential of N-arylsuccinimides was studied in male Fischer 344 rats. Rats were administered a single intraperitoneal (i.p.) injection of an N-arylsuccinimide derivative (0.4 or 1.0 mmol/kg) or sesame oil (2.5 ml/kg), and the renal function monitored at 24 and 48 h. The parent compound in this series, N-phenylsuccinimide (NPS), had previously been shown to induce only minimal renal effects, having no effect on urine volume, blood urea nitrogen concentration, kidney weight, p-aminohippurate accumulation or renal morphology. Only an increase in tetraethylammonium uptake has been observed following NPS administration to rats. These effects were not enhanced by reducing aromaticity (N-cyclohexylsuccinimide (NCS]. Compounds with increased aromaticity N-(1-naphthyl)succinimide (NNS), N-(1-anthracenyl)succinimide (1-NAS) and N-(9-anthracenyl)succinimide (9-NAS)--also only weakly affected renal function. However, NNS (1.0 mmol/kg) and, to a lesser degree, 9-NAS (1.0 mmol/kg) proved to be hepatotoxins. Liver damage was most pronounced near central vein regions of the lobule and least evident around periportal sites. Damaged liver tissue exhibited unusually large deposits of connective tissue and hypertrophied hepatocytes with numerous vacuoles in their cytoplasm. Therefore, derivatives of NPS with increased or decreased aromaticity relative to the parent compound do not exhibit the ability to induce moderate or marked nephrotoxicity. However, increasing aromaticity did produce the derivatives NNS and 9-NAS, which are hepatotoxins. These compounds represent the first members in this series of compounds to induce acute hepatotoxicity.


Subject(s)
Chemical and Drug Induced Liver Injury/physiopathology , Kidney Diseases/chemically induced , Succinimides/toxicity , Animals , Chemical and Drug Induced Liver Injury/pathology , In Vitro Techniques , Kidney/pathology , Kidney Cortex/drug effects , Kidney Cortex/metabolism , Kidney Diseases/pathology , Kidney Diseases/physiopathology , Liver/pathology , Male , Organ Size/drug effects , Rats , Rats, Inbred F344 , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...